Showing results (81-90 of 140) with videos related to
Sort By:
Pageof 14
Acta Oncologica (Stockholm, Sweden)|September 8, 2015
Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose paintingJacob H Rasmussen, Ivan R Vogelius, Marianne C Aznar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical TrialMarie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, et al.American Journal of Nuclear Medicine and Molecular Imaging|August 1, 2013
Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CTRasmus S Ripa, Andreas Knudsen, Anne Mette F Hag, et al.Blood|September 10, 2005
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaMartin Hutchings, Annika Loft, Mads Hansen, et al.Diagnostics (Basel, Switzerland)|February 13, 2025
Circulating Tumor DNA and [<sup>18</sup>F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLCHeidi Ryssel, Lise Barlebo Ahlborn, Danijela Dejanovic, et al.The International Journal of Cardiovascular Imaging|February 16, 2020
Clinical usefulness of FDG-PET/CT for identification of abnormal extra-cardiac foci in patients with infective endocarditisSarah Louise Kjølhede Holle, Malene Højgaard Andersen, Christine Falk Klein, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
<sup>64</sup>Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine NeoplasmsEsben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, et al.Haematologica|December 31, 2011
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costsTarec Christoffer El-Galaly, Karen Juul Mylam, Peter Brown, et al.Diagnostics (Basel, Switzerland)|April 23, 2022
First-in-Human Study of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET for Integrin α<sub>v</sub>β<sub>3</sub> Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging AbilityMalene Martini Clausen, Esben Andreas Carlsen, Camilla Christensen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
A Prospective Study Comparing <sup>99m</sup>Tc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with <sup>18</sup>F-Fluoride PET/CT and <sup>18</sup>F-Fluoride PET/MRI for Diagnosing Bone MetastasesJohan Löfgren, Jann Mortensen, Sine H Rasmussen, et al.Pageof 14